Zealand’s GLP-1/GLP-2 drug bounces back with new Phase 1b da­ta

Zealand Phar­ma’s GLP-1/GLP-2 re­cep­tor dual ag­o­nist showed promis­ing weight loss in an ear­ly-stage tri­al af­ter a pre­vi­ous ef­fort with low­er dos­es end­ed with “un­der­whelm­ing” ef­fi­ca­cy …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER